Background: Hypertension is one of the main causes of cardiovascular disease. Patients with hypertension have increase risk of heart failure compared to populations with normal blood pressure. Clinical evidence shows diastolic dysfunction (DD) can lead to heart failure. Diagnostic of DD with echocardiography is important but access to echocardiography machines is limited compared to electrocardiography (ECG). ECG research correlates P-wave dispersion (PWD) with DD. The aim of this study is to determine the value of PWD to diagnose DD in patients with hypertension. Methods: A cross sectional study was conducted in patients with hypertension at Dr. Sardjito Hospital. Patients received echocardiography, ECG, blood pressure measurement and data recording. The diastolic dysfunction was determined based on 2016 ASE/EACVI criteria. We conducted ROC analysis to determine the cut-off point of P-wave dispersion and the area under the curve (AUC) value, and bivariate analysis on demographic and clinical factors related to PWD. Multivariate analysis was performed to determine the independent factors affecting PWD. Results: 113 patients met the criteria of the study subjects, with 47 men (37.2%), mean age 58.32±11.17 years. Thirteen (11.5%) subjects had DD and 37 subjects (32.7%) with increased PWD. Results showed increased PWD above 71.4 m.s with AUC 76.2%, sensitivity 75%, specificity 72.2%, positive predictive value 33.3%, negative predictive value 96%, and accuracy of 72.5% in diagnosing DD. Conclusion: This is the first study to examine the diagnostic value of PWD to detect diastolic function based on 2016 ASE/EACVI criteria. We found PWD above cut-off point 71.4 m.s has a moderate diagnostic value for detecting DD in patients with hypertension.
INTRODUCTION
Hypertension is one of the leading cause of cardiovascular disease. Study in Malaysia showed that the prevalence of hypertension reached 24%
and is a major cause of heart failure with high mortality. 1 Hypertension causes thickening of the ventricular wall as compensation for increased pressure on the ventricular wall which ultimately results in concentric hypertrophy of the left ventricle and causes diastolic dysfunction. 2 In the left ventricular diastolic dysfunction condition, there will be an increase in end diastolic pressure and increase of the dimension of the left atrium.
The increased left atrial pressure and dimension increase the risk of atrial fibrillation, which in turn will increase diastolic dysfunction severity and worsening of symptoms of heart failure 3 .
Diagnosing diastolic dysfunction with echocardiography is important because of the large number of morbidities that can result from poorly handled diastolic dysfunction, but access to echocardiography machines is limited.
Electrocardiography machines are commonly found in health care providers. We examined ECG parameters, which could provide diagnostic indicators to diastolic dysfunction (DD).The ECG examination correlates P-wave dispersion (PWD) with DD. In this study, PWD was obtained by substracting the shortest duration of the P-wave from the longest P-wave duration in various ECG leads.One recent study found that P-wave parameters correspond to left atrial volume index (LAVI) and left ventricular diastolic dysfunction. 4 We conducted this study in order to examine the diagnostic value of P-wave dispersion in predicting the occurence of DD in patients with hypertension.
METHOD
An analytic observational study using cross sectional design was conducted in RSUP Dr. were assessed using 2x2 tables.
Ethical Consideration
This study was ethicaly approved by the ethical committee of medical research Faculty of Medicine,Universitas Gadjah Mada, Yogyakarta and permission from the Dr. Sardjito General Hospital Yogyakarta, Indonesia.
RESULTS

This research was conducted from March
to April 2017 in Dr. Sardjito Hospital. There were 270 subjects with a history of hypertension. The total subjects met the inclusion criteria were 113 subjects.
The subjects consisted of 42 men (37%) and 71 women (63%). The mean age of the subjects was 58.29 ± 11.21 years with median systolic blood pressure 140 mmHg, while diastolic blood pressure with median 80 mmHg. Seven subjects (6.1%) had ECG recording indicating ischemic heart disease and 13 subjects (11.5%) had diabetes. Fifty-three subjects (47%) received one or more antihypertensive medications, with most subjects using calcium group blockers 29 subjects (25.6%), followed by ARB 27 subjects (23.9%) and ACE inhibitor 11 subjects (9.7%).
The ROC curve analysis showed AUC value 76.2% (p=0.003; 95% CI 0.620% -0.920%)
at P-wave dispersion cut-off point ≥ 71.4 ms with sensitivity 75% and spesificity 72.3%. Area under the curve (AUC) are in the area 70-80% so that the strength of diagnostic test in this study is moderate. 7 When we continued to analyze the P-wave dispersion with cut-off point 71.4 ms using 2x2 Bivariate analysis was performed on each confounding factor of P-wave dispersion ( Table   2 ). There were significant differences between groups of subjects with ischemic heart disease and those who received therapy of ARB (p <0.05), while subjects with diastolic blood pressure ≥ 90
mmHg, who had a history of smoking, and had beta-blocker therapy reached a value of p <0.25, so further analysis was required with multivariate analysis.
Based on the results of the multivariate analysis, it can be concluded that the use of ARB is an independent variable that affects the P-wave dispersion in this study with p value <0.05.
DISCUSSION
Our study involved 113 subjects with the majority of subjects being female (62.8%)
with an average age of 58.32 ± 11.17 years. Figure 2 . Sensitivity-specificity graph to define optimal cut-off point of P-wave dispersion to detect diastolic function in patients with hypertension The differences of these results may be due to differences in characteristics of the study subjects, diagnostic criteria for diastolic dysfunction, and ECG reading methods. Subjects in our study were all patients with hypertensive and there was a significant difference in the proportion of subjects with diastolic dysfunction compared to the total number of study subjects.
In the study by Taha et al. (2015) the study subjects were the patients who were planned to do the stress ECG test with the inclusion criteria of patients with negative stress test,and a history of hypertension was only found in 38.5% of all subjects. The diastolic dysfunction criteria in this study was to use the ratio parameter E/e' where the value of ≥ 15 was classified as diastolic dysfunction, with 60% of subjects having diastolic dysfunction. The ECG was read using a magnifying glass to obtain P-wave dispersion with characteristics: mean 47 ± 10 ms in subjects with normal diastolic function and 69 ± 10 ms in subjects with diastolic dysfunction. A study from Dilaveris et al. (1999) comparing various P-wave measurement methods to obtain P-wave duration, found that measurements are more stable and reliable by using high resolution digital screens compared to reading using ECG paper using magnifying glass and calipers. 9 The AUC value of this research is 76.2%
in the range of 70 -80% so that the strength of the diagnostic test in this study is moderate. 54% of subjects suffering from hypertension with diastolic dysfunction were divided into 3 classes in this study, and it was found that P-wave dispersion increased significantly in patients with diastolic dysfunction (53 ± 9 m.s vs. 43 ± 9; p <0.01), but the difference of P-wave dispersion between the 3 classes of diastolic dysfunction was not significantly different (p> 0.05). 11 Another study compared P-wave dispersion in hypertensive patients with and without a paroxysmal AF history found that P-wave dispersion > 44 m.s can distinguish hypertensive patients with and without paroxysmal atrial fibrillation with 77% sensitivity and 62% specificity. 12 Research to diagnose diastolic dysfunction by using P-wave dispersion with all subjects who were hypertension patients has never been done beforeusing the ASE/ EACVI 2016 recommendations. To the author best knowledge, this research is the first to apply the new guidelines to use P-wave dispersion to diagnose diastolic dysfunction.
Ischemic heart disease has been known to influence P-wave dispersion based on studies in patients with stable angina. 13 Another study found no significant differences between the two groups. 11 This result is similar to our study that had significant ischemic heart disease on P-wave dispersion in bivariate tests but not significant after multivariate tests. This result is probably due to our exclusion of patients with decreased fraction ejection where most of the causes are ischemic heart disease.
Gender and age did not show statistically (2008) there were no significant differencesof P-wave dispersion in terms of age and sex in hypertensive patients compared with normal patients. 15 In our study systolic and diastolic blood pressure variables also did not differ significantly (p=0.946 and 0.052) respectively. The use of CCB medication was not significantly correlated to P-wave dispersion.
The subjects in our study mostly used CCB medication in the form of amlodipine. be due to the small number of subjects using ACE inhibitors, i.e.11 subjects (9.7%) of a total of 113 subjects when compared to the proportion of subjects in the previous study. 18, 19 Previous studies with subjects of hypertensive patients and history of atrial fibrillation showed that valsartan and ramipril had a similar effect of decreasing blood pressure compared to amlodipine, but valsartan had a better reduction in P-wave dispersion compared to ramipril while amlodipine did not decrease P-wave dispersion. The mechanisms underlying the effects of P-wave dispersion reduction are not known for certain, but ARB and ACE inhibitors are considered to have antiarrhythmic effects through various pathways such as inhibiting ion channel function, angiotensin II induced angiotensic fibrosis, reducing atrial strain, improving left ventricular hemodynamic, and modulation of sympathetic nerve activation. 16, 20, 21 Our study found that betablocker drugs did not affect P-wave dispersion, which is different from previous studies. 19, 22, 23 This finding can be due to differences in the proportion of patients using beta blockers and the type of beta blockers used. The subjects of this study mostly used bisoprolol where the effect of bisoprolol on P-wave dispersion has not been studied previously.
LIMITATIONS
Several limitations should be considered in interpreting our results. The proportion of subjects with diastolic dysfunction is small when compared to the total number of subjects, so the result may not be able to accurately describe the condition in the general population. Since research subjects continued to receive antihypertensive therapy, the variety of medication used and their effect on P-wave dispersion could not be completely eliminated as confounding variables.
CONCLUSION
This research is the first study to investigate the diagnostic value of P-wave dispersion to detect diastolic function using ASE/EACVI 2016
recommendations. Our findings demonstrate that P-wave dispersion above cut-off point 71.4 m.s has moderate diagnostic value to detect diastolic dysfunction.
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